Abstract
In the compound 48/80 lethality test in rats, which is based on the specific activation of mast cells, astemizole was selected as a potent, long-acting and orally very effective inhibitor of anaphylactoid shock. In comparison to other histamine-H1 antagonists astemizole was also a very effective inhibitor of allergic reactions in rats and dogs and remarkably free of non-specific interactions with other biological amines and normal body functions. In numerous tests no evidence of central activity was found and toxicity studies have shown astemizole to be a very safe drug despite of its long duration of action. A daily dose of 10 mg of astemizole was found clinically free of side-effects and more effective than conventional antihistamine treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
C.J.E. Niemegeers, F. Awouters, J.M. Van Nueten, S. De Nollin andP.A.J. Janssen,Protection of rats from compound 48/80-induced lethality. A simple test for inhibition of mast cell-mediated shock, Arch. int. Pharmacodyn. Ther.234, 164–176 (1978).
C.J.E. Niemegeers, F.H.L. Awouters andP.A.J. Janssen,The in vivopharmacological profile of histamine H 1 antagonists in the rat, Drug Develop. Res.2, 559–566 (1982).
P.M. Laduron, P.F.M. Janssen, W. Gommeren andJ.E. Leysen, In vitroand in vivobinding characteristics of a new long-acting histamine H 1-antagonist, astemizole. The Medicine Publishing Foundation, Symposium Series 11, Oxford, pp. 11–23 (1984).
A. Wauquier, W.A.E. Van Den Broeck, F. Awouters andP.A.J. Janssen,Further studies on the distinctive sleep-wakefulness profiles of antihistamines (astemizole, ketotifen, terfenadine) in dogs, Drug Develop. Res.4, 617–625 (1984).
F. Awouters, C.J.E. Niemegeers andP.A.J. Janssen,Interaction of astemizole and other drugs with passive cutaneous anaphylactic and histamine-, serotonin-, and compound 48/80-induced skin reactions in the rat: a procedure to determine antiallergic effectiveness, Drug Develop. Res.5, 137–145 (1985).
F.H.L. Awouters, C.J.E. Niemegeers andP.A.J. Janssen,Pharmacology of the specific histamine-H 1 antagonist astemizole, Arzneimittel. Forsch.33, 381–388 (1983).
N. Rombaut andG. Vanden Bussche,Survey on all clinical results of astemizole, Z. Hautkr. 60 (Suppl. 1), 39–42 (1985).
W. Karrass,Hismanal, a non-sedating H 1-antihistamine, Z. Hautkr. 60 (Suppl. 1), 59–66 (1985).
G.L. Sussman andM. Kobric,The treatment of seasonal allergic rhinitis with astemizole, a non-sedating antihistamine. Results of an open, multicenter clinical trial, Today's Ther. Trends2, 11–19 (1985).
L.B. Krause andS. Shuster,A comparison of astemizole and chlorpheniramine in dermographic urticaria, Br. J. Dermatol.112, 447–453 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Niemegeers, C.J.E., Awouters, F. & Janssen, P.A.J. The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole. Agents and Actions 18, 141–144 (1986). https://doi.org/10.1007/BF01988005
Issue Date:
DOI: https://doi.org/10.1007/BF01988005